Does high fecal secretory IgA with normal calprotectin indicate immune reactivity without neutrophilic injury?

The assessment of fecal biomarkers provides a window into the distinct immunological processes occurring within the gastrointestinal tract. Research indicates that fecal secretory IgA (sIgA) and fecal calprotectin reflect different arms of the immune system, and their divergent levels can help characterize the nature of intestinal reactivity.

Clinical effectiveness and biomarker utility

Fecal secretory IgA is an established indicator of the adaptive mucosal immune response. It is the primary immunoglobulin produced by the Gut-Associated Lymphoid Tissue (GALT) and serves as a first-line defense by neutralizing pathogens and preventing the adhesion of luminal antigens to the intestinal lining.

• sIgA as a Marker of Reactivity: Elevated fecal sIgA levels signify heightened GALT activity. In clinical settings, this is often observed in response to chronic exposure to luminal antigens, including food proteins or microbial imbalances.
• Calprotectin as a Marker of Injury: Fecal calprotectin (FC) is a highly specific surrogate for neutrophilic inflammation. Because calprotectin makes up ~60% of the protein in neutrophil cytoplasm, its presence in stool directly correlates with the migration of these white blood cells into the gut lumen. Normal FC levels (typically <50–100 µg/g) have a high negative predictive value for significant organic inflammation or neutrophilic tissue injury.

Mechanistic explanations

The discordance between high sIgA and normal calprotectin is explained by the separation of adaptive immune monitoring from innate inflammatory destruction.

• Adaptive Priming: The process begins in Peyer’s patches, where M-cells transport luminal antigens to dendritic cells. These cells prime B-cells to undergo class switching to IgA-producing plasma cells. This "immune reactivity" increases sIgA production as a protective measure to sequester antigens.
• Absence of Neutrophil Recruitment: If this immune response successfully manages the antigenic load without triggering a massive cytokine storm or tissue damage, neutrophils are not recruited to the mucosa. Consequently, calprotectin—the hallmark of the innate, destructive inflammatory response—remains within normal ranges.
• Biological Stability: Both markers are stable in stool, making them reliable for assessing these physiological states. sIgA is protected from degradation by its secretory component, while calprotectin’s calcium-binding properties provide resistance to proteolysis.

Clinical implications for elderly patients

In older adults (e.g., age 74), maintaining mucosal barrier integrity is critical. A profile showing high sIgA with normal calprotectin suggests that the mucosal immune system is actively responding to a stimulus—such as a shift in the microbiome or a food sensitivity—but has not yet progressed to overt, neutrophil-mediated inflammatory damage like that seen in inflammatory bowel disease (IBD).

Bottom line

High fecal secretory IgA paired with normal calprotectin indicates an active mucosal immune response to luminal antigens (immune reactivity) in the absence of significant neutrophilic infiltration or tissue injury (inflammation). This profile often points toward non-inflammatory immune activation, such as non-IgE-mediated food hypersensitivities or localized adaptive responses.